The tricyclic antidepressants—Inhibition of norepinephrine uptake as related to potentiation of norepinephrine and clinical efficacy

Sigg, 1959, Can. psychiat. Ass. J., 4

Sigg, 1963, J. Pharmac. exp. Ther., 142, 13

Thoenen, 1964, J. Pharmac. exp. Ther., 144, 405

Hertting, 1961, J. Pharmac. exp. Ther., 134, 146

Whitby, 1961, J. Pharmac. exp. Ther., 132, 193

Daly, 1966, J. med. Chem., 9, 273, 10.1021/jm00321a001

Patterson, 1965, Analyt. Chem., 37, 854, 10.1021/ac60226a017

Overall, 1969, Clin. Pharmac. Ther., 10, 36, 10.1002/cpt196910136

Theobald, 1965, Arzneimittel Forsch., 15, 117

Gluckman, 1969, Psychopharmacologia, 15, 169, 10.1007/BF00411167

Bennett, 1967, 375

Kalsner, 1969, Br. J. Pharmac. Chemother., 35, 428, 10.1111/j.1476-5381.1969.tb08284.x

Carlsson, 1969, Eur. J. Pharmac., 5, 367, 10.1016/0014-2999(69)90114-9